As previously reported by heart wire, BOOST was the first randomized trial to look at intracoronary bone-marrow cell therapy after acute MI. The findings at six months showed a significant increase in ...

Chimeric antigen receptor-T cell (CAR-T cell) therapies have been a significant advance in the field of cancer immunotherapeutics in recent years, particularly for B-cell malignancies. Yet, this ...

A new study has shed light on a previously poorly understood aspect of breast cancer recurrence: how cancer cells survive in bone marrow despite targeted therapies. A study from researchers at the ...

EMBL scientists discovered self-sustaining inflammatory circuits in the bone marrow stem cell microenvironment that precede blood cancers. The illustration shows cancer cells against a background of ...

Their key finding was the mechanism by which a normal cell type, mesenchymal stem cells, in the bone marrow supports the cancer cells. "We discovered that the breast cancer cells require direct ...

Changes in Clinical Context for Kaposi's Sarcoma and Non-Hodgkin Lymphoma Among People With HIV Infection in the United States We assessed the percentage of BM blasts from TNCs and NECs in 3,692 ...

Ramaiah Memorial Hospital bags FACT accreditation for global bone marrow transplant standards: Our Bureau, Bengaluru, Thursday, February 19, 2026, 12:15 Hrs [IST] Ramaiah Memorial ...